Skip to main content
Fig. 5 | Biological Procedures Online

Fig. 5

From: Establishment and Fractionation of Metastatic Axillary Lymph Node Cell Suspension for Determination of Protein Expression Levels of Nuclear cFOS and Cytosolic TGFβ1 from Breast Cancer Patients

Fig. 5

Comparative scatter diagrams of ALN biomarkers of BC patients described in Tables 1 & 2. A diameter of tumor deposits of metastatic ALN; horizontal bar represent median value; Median 13.5; Mean 23.86 ± S.E.M. 12.74; number of samples = 5. B Levels of nuclear cFOS detected in FNCS-derived extracts of nonmalignant ALN tissue as a control versus that of the autologous metastatic ALN tissue; horizontal bars represent median values for nALN versus mALN: Control: Median 2.81; Mean 4.89 ± SEM 1.88; number of samples = 6; Metastatic: Median 13.2; Mean 12.47 ± SEM 1.63; number of samples = 3; Median significance p > 0.05. Here no significant difference between C and M. C. Levels of cytosolic TGFβ1 in FNCS-derived extracts of nomal ALN tissue as a control versus that of the autologous metastatic ALN tissue: horizontal bars represent median values; p, level of significance for nALN versus mALN: Control: Median 0.48; Mean 0.55 ± SEM 0.08; number of samples = 6; Metastatic: Median 1.05; Mean 1.41 ± SEM 0.40; number of samples = 6. Median significantly different, p < 0.05

Back to article page

Biological Procedures Online

ISSN: 1480-9222

Contact us